EndoQuest Robotics Appoints Jared Eben as Chief Commercial Officer
EndoQuest Robotics has announced the appointment of Jared Eben as its new chief commercial officer. The executive leadership update comes as the medical technology company prepares for the anticipated market introduction of its flexible robotic surgery platform.
Expanding Executive Leadership
According to the company announcement, Eben joins EndoQuest to oversee the commercial strategy and market preparation for its flagship surgical technology. Medical device companies typically strengthen their commercial teams ahead of regulatory milestones and product rollouts to establish hospital partnerships and support physician training programs.
Focus on Flexible Robotic Surgery
The company develops flexible robotic systems designed for minimally invasive procedures. Surgical robotics platforms aim to enhance precision and maneuverability during operations compared to traditional laparoscopic instruments. EndoQuest has been developing its physician console and flexible robotic instruments to navigate natural orifices and tight anatomical spaces.
- Jared Eben joins as chief commercial officer
- Appointment precedes planned product launch
- Focus centers on flexible robotic surgery systems
As the company moves closer to its commercialization phase, further updates regarding regulatory status, clinical deployment timelines, and institutional availability are expected from corporate leadership.
